4//SEC Filing
Anthera Pharmaceuticals Inc 4
Accession 0001214659-16-015272
CIK 0001316175operating
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 6:49 PM ET
Size
5.5 KB
Accession
0001214659-16-015272
Insider Transaction Report
Form 4
Thompson David E.
Director
Transactions
- Award
Stock Option (right to buy)
2016-12-08+83,910→ 83,910 totalExercise: $2.00Exp: 2026-12-08→ Common Stock (83,910 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 12 equal monthly installments from the vesting commencement date of December 8, 2016. This stock option is fully exercisable on December 8, 2017.
Documents
Issuer
Anthera Pharmaceuticals Inc
CIK 0001316175
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001316175
Filing Metadata
- Form type
- 4
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 6:49 PM ET
- Size
- 5.5 KB